Current and Novel Inhibitors of HIV Protease
The design, development and clinical success of HIV protease inhibitors represent one of the most remarkable achievements of molecular medicine. This review describes all nine currently available FDA-approved protease inhibitors, discusses their pharmacokinetic properties, off-target activities, sid...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Molecular Diversity Preservation International (MDPI)
2009
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185513/ |